From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma

Molecular biology studies of uveal melanoma have resulted in the development of novel immunotherapy approaches including tebentafusp—a T cell–redirecting bispecific fusion protein. More biomarkers are currently being studied. As a result, combined immunotherapy is being developed as well as immunoth...

Full description

Bibliographic Details
Main Authors: Kamil J. Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Damiano Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Rutkowski, Yacoub A. Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michal Fiedorowicz, Anna M. Czarnecka
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Current Oncology
Subjects:
uveal melanoma
biomarkers
immunotherapy
theranostics
nanomedicine
Online Access:https://www.mdpi.com/1718-7729/31/2/58

Similar Items

Similar Items